e-Edition
Obituaries
Special Sections
Special Occasions
Contact
Subscribe
Paywall Login
Login to Comment
Register
December 11th, 2017
jobs
homes
Menu
Home
News
Sports
Business
Entertainment
Classifieds
Commentary
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries
Cellectis S.A. - American Depositary Shares
(NQ:
CLLS
)
4.690
-0.090 (-1.88%)
Streaming Delayed Price
Updated: 4:00 PM EST, Nov 21, 2025
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Headline News about Cellectis S.A. - American Depositary Shares
< Previous
1
2
3
4
5
Next >
Why Cellectis Stock Is Trading Higher Today
↗
November 19, 2025
Cellectis reports strong Nature Communications data showing CssDNA boosts non-viral gene insertion efficiency and supports long-term therapeutic potential.
Via
Benzinga
European ADRs Navigate Choppy Waters: Pharma Sector Shows Resilience Amidst Broader Market Volatility
November 19, 2025
European American Depositary Receipts (ADRs) have recently experienced a period of significant fluctuation, reflecting a broader climate of market volatility that has ripple across global financial...
Via
MarketMinute
Topics
Artificial Intelligence
Economy
Supply Chain
Cellectis Earnings Preview
↗
November 06, 2025
Via
Benzinga
Olema Pharmaceuticals, Exelixis, Genmab And Other Big Stocks Moving Lower In Monday's Pre-Market Session
↗
October 20, 2025
Via
Benzinga
Earnings Scheduled For August 4, 2025
↗
August 04, 2025
Via
Benzinga
Earnings Scheduled For May 12, 2025
↗
May 12, 2025
Via
Benzinga
Earnings Scheduled For November 7, 2025
↗
November 07, 2025
Via
Benzinga
Thursday's session: gap up and gap down stocks
↗
October 16, 2025
Let's have a look at what is happening on the US markets on Thursday. Below you can find the gap up and gap down stocks in today's session.
Via
Chartmill
Enerpac Tool Group Posts Upbeat Results, Joins Praxis Precision Medicines, J B Hunt, Salesforce And Other Big Stocks Moving Higher On Thursday
↗
October 16, 2025
Via
Benzinga
Top 2 Health Care Stocks That May Keep You Up At Night This Month
↗
October 16, 2025
Via
Benzinga
Stay updated with the stocks that are on the move in today's pre-market session.
↗
October 16, 2025
The US market session of Thursday has yet to be opened, let's have a look at the top gainers and losers in the pre-market session today.
Via
Chartmill
Wondering what's happening in today's pre-market session?
↗
September 29, 2025
Before the opening bell on Monday, let's take a glimpse of the US markets and explore the top gainers and losers in today's pre-market session.
Via
Chartmill
12 Health Care Stocks Moving In Monday's Pre-Market Session
↗
September 29, 2025
Gainers Dogwood Therapeutics (NASDAQ: DWTX) stock moved upwards by 80.1% to $9.94 during Monday's pre-market session. The market value of their outstanding shares is at $10.5 million.
Via
Benzinga
Inventiva, MoonLake Immunotherapeutics And Other Big Stocks Moving Lower In Monday's Pre-Market Session
↗
September 29, 2025
U.S. stock futures were higher this morning, with the Dow futures gaining more than 100 points on Monday. Shares of Inventiva ADR (NASDAQ: IVA) fell sharply in today's pre-market trading following H1...
Via
Benzinga
Topics
Stocks
Why Merus Shares Are Trading Higher By 38%; Here Are 20 Stocks Moving Premarket
↗
September 29, 2025
Shares of Merus NV (NASDAQ: MRUS) rose sharply in today's pre-market trading. Genmab announced plans to acquire Merus for $8 billion in all-cash deal adding breakthrough therapy Petosemtamab to its...
Via
Benzinga
12 Health Care Stocks Moving In Friday's Pre-Market Session
↗
September 19, 2025
Via
Benzinga
Top 5 Biotech Stocks With Strong Momentum
↗
August 28, 2025
Top 5 biotech stocks jumping into the top 10% momentum this week—ADCT, ARQT, CLLS, ENTO, HOTH—amid rapid sector rallies.
Via
Benzinga
Why Celestica Shares Are Trading Higher By Around 12%; Here Are 20 Stocks Moving Premarket
↗
July 29, 2025
Via
Benzinga
12 Health Care Stocks Moving In Friday's Intraday Session
↗
July 25, 2025
Via
Benzinga
What's going on in today's session
↗
July 25, 2025
Here are the top movers in Friday's session, showcasing the stocks with significant price changes.
Via
Chartmill
12 Health Care Stocks Moving In Monday's Intraday Session
↗
July 14, 2025
Via
Benzinga
Cellectis Charts Course for 2025 With Boost From AstraZeneca Deal
April 22, 2025
Cellectis, backed by AstraZeneca funding and a multi-year cash runway, is advancing its prioritized allogeneic CAR-T pipeline toward pivotal 2025 milestones.
Via
MarketBeat
The market is filled with gapping stocks in Friday's session.
↗
April 11, 2025
Today's session on Friday is marked by notable gaps in various stocks. Stay informed with the gap up and gap down stocks in today's session.
Via
Chartmill
12 Health Care Stocks Moving In Friday's After-Market Session
↗
March 14, 2025
Via
Benzinga
12 Health Care Stocks Moving In Friday's Pre-Market Session
↗
March 14, 2025
Via
Benzinga
Why Rubrik Shares Are Trading Higher By Over 20%; Here Are 20 Stocks Moving Premarket
↗
March 14, 2025
Via
Benzinga
Earnings Scheduled For March 13, 2025
↗
March 13, 2025
Via
Benzinga
CLLS Stock Earnings: Cellectis Beats EPS, Beats Revenue for Q2 2024
↗
August 06, 2024
CLLS stock results show that Cellectis beat analyst estimates for earnings per share and beat on revenue for the second quarter of 2024.
Via
InvestorPlace
CLLS Stock Earnings: Cellectis Beats EPS, Beats Revenue for Q1 2024
↗
May 28, 2024
CLLS stock results show that Cellectis beat analyst estimates for earnings per share and beat on revenue for the first quarter of 2024.
Via
InvestorPlace
12 Health Care Stocks Moving In Tuesday's Pre-Market Session
↗
May 07, 2024
Via
Benzinga
< Previous
1
2
3
4
5
Next >
Stock Quote API & Stock News API supplied by
www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the
Privacy Policy
and
Terms Of Service
.
© 2025 FinancialContent. All rights reserved.